Michael practices general securities and corporate law, with extensive experience representing U.S. and foreign issuers and underwriters in capital markets transactions, including public offerings, secondary offerings, private placements, debt offerings, and debt restructuring transactions such as exchange offers. In addition, he assists public companies with securities law compliance, disclosure issues, and corporate governance matters and advises pharmaceutical, biotech, and other life sciences companies on a broad range of corporate, operational, and transactional matters, including strategic alliances, joint ventures, collaborations (including co-promotion and co-commercialization), and licensing arrangements.